Dr. Ran Rubinstein Introduces Renuva(R): A Breakthrough Non-Surgical Fat Restoration Treatment in New York and New Jersey

health news

Double board-certified facial plastic surgeon now offers Renuva at Laser & Cosmetic Surgery Specialists in Newburgh, NY and Rubinstein Plastic Surgery Center in Montvale, NJ

NEWBURGH, NY AND MONTVALE, NJ / ACCESS Newswire / May 6, 2026 / Ran Y. Rubinstein, MD, a double board-certified facial plastic surgeon serving patients throughout New York and New Jersey, has announced the addition of Renuva® to his practice’s non-surgical treatment menu. The injectable treatment is now available at Laser & Cosmetic Surgery Specialists in Newburgh, NY and Rubinstein Plastic Surgery Center in Montvale, NJ, offering patients in the Hudson Valley and Bergen County a new option for addressing localized facial volume loss without surgery.

Dr. Ran Rubinstein's approach to injectable treatments emphasizes precision, facial harmony, and natural-looking results.

A Different Approach to Injectable Volume Restoration

As the face ages, fat beneath the skin gradually diminishes. This natural process can lead to subtle hollowing, contour irregularities, and small depressions that affect facial balance and overall appearance. While dermal fillers and biostimulatory injectables have long been the primary non-surgical tools for addressing these changes, Renuva introduces a distinct mechanism that sets it apart from existing options.

Renuva is an injectable adipose matrix derived from purified donor fat tissue. During processing, cellular components are removed while structural elements naturally found in fat tissue – including collagen, proteins, and growth factors – are preserved. When injected beneath the skin, this matrix provides a scaffold within the tissue that supports the body’s ability to generate new fat cells over time. Rather than providing immediate volume the way a traditional filler does, Renuva works gradually, allowing improvements to develop naturally over several months as the body integrates the matrix and populates the treated area with new fat cells and blood vessels.

This regenerative approach makes Renuva particularly well-suited for smaller, localized areas of volume loss – including subtle facial asymmetries, mild contour irregularities, depressions associated with scarring or prior procedures, and areas of localized fat loss within the face – where gradual, natural-looking improvement is the goal.

How Renuva Differs From Other Injectables

The injectable landscape includes several categories of treatments, each working through a different mechanism. Dermal fillers, such as hyaluronic acid-based products, provide immediate volume by placing a gel-like substance beneath the skin, with results typically lasting several months to over a year. Biostimulatory injectables like Sculptra and Radiesse work by stimulating the body’s collagen production, gradually improving skin structure and firmness over time.

Renuva operates differently from both. Rather than adding filler material or stimulating collagen alone, Renuva provides an adipose tissue matrix that supports the body’s ability to generate new fat cells – the same type of tissue lost during the natural aging process. Because the treatment relies on tissue integration rather than a filler substance, results develop progressively and may offer longer-lasting improvement than many traditional injectable options. Individual results vary, and patients should discuss realistic expectations during their consultation.

Who Is a Candidate for Renuva?

Renuva may be appropriate for patients who have mild to moderate localized fat loss, want gradual and natural-looking improvement, prefer a non-surgical option, and have small contour irregularities or depressions that may not require or benefit from fat grafting surgery. Because the treatment is designed for smaller corrections rather than significant structural augmentation, it is most effective when used in carefully selected areas where targeted volume restoration is needed.

Not every type of facial volume loss is best addressed with Renuva. In some cases, dermal fillers, biostimulants, or surgical procedures such as fat grafting may provide more predictable results. Dr. Rubinstein evaluates each patient’s facial anatomy, skin quality, and aesthetic goals during consultation to determine whether Renuva or another treatment approach is most appropriate.

Treatment and Recovery

Renuva injections are performed in the office and typically take less than an hour. A local anesthetic may be used to improve comfort during the procedure. Most patients can return to normal daily activities shortly after treatment. Temporary effects such as mild swelling, minor bruising, or tenderness at the injection site may occur but typically resolve within several days.

Because Renuva works through gradual tissue integration, improvements become more noticeable over several months rather than immediately after treatment. As the treated area develops new fat cells, results can appear soft and natural – consistent with the surrounding facial tissue.

Availability at Two Locations

Renuva is now available at both of Dr. Rubinstein’s practice locations. Patients in the Hudson Valley, including those from Orange County, Middletown, Goshen, Cornwall, Poughkeepsie, Fishkill, and the surrounding communities, can access treatment at Laser & Cosmetic Surgery Specialists in Newburgh, NY. Patients in Bergen County and the greater New Jersey area can access treatment at Rubinstein Plastic Surgery Center in Montvale, NJ.

About Dr. Ran Y. Rubinstein

Ran Y. Rubinstein, MD is a double board-certified facial plastic surgeon certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology-Head and Neck Surgery. With more than 20 years of experience in both private and academic practice, Dr. Rubinstein specializes in facial aesthetic procedures and offers a comprehensive range of surgical and non-surgical treatments at his New York and New Jersey locations. He is an active member of the American Society for Laser Medicine and Surgery.

His approach to injectable treatments emphasizes precision, facial harmony, and natural-looking results. Every treatment plan is tailored to the patient’s facial anatomy and long-term aesthetic goals, ensuring outcomes that enhance facial balance without appearing overdone.

Dr. Rubinstein believes in giving back through teaching his peers. This began during his tenure as an Assistant Clinical Professor at New York Presbyterian Hospital. He now dedicates his time as a national aesthetic injection trainer and offers education at Rubinstein Aesthetic Training Center, located at his Montvale, New Jersey practice.

Patients interested in learning more about Renuva or scheduling a consultation are encouraged tocontact the office directly.

About Laser & Cosmetic Surgery Specialists

Laser & Cosmetic Surgery Specialists is a physician-led aesthetic practice located in Newburgh, NY, serving patients throughout Orange County and the Hudson Valley, including Middletown, Goshen, Cornwall, Poughkeepsie, and the surrounding communities. The practice offers advanced facial plastic surgery, comprehensive Med Spa services, and non-surgical facial rejuvenation treatments under physician supervision, with a focus on natural-looking results tailored to each patient’s anatomy and goals.

About Rubinstein Plastic Surgery Center

Rubinstein Plastic Surgery Center is a physician-led aesthetic practice located in Montvale, NJ, serving patients throughout Bergen County, including Mahwah, Ramsey, Saddle River, Paramus, and the surrounding communities. The practice offers advanced facial plastic surgery, comprehensive Med Spa services, and an aesthetic training center.

Media Contact

Laser & Cosmetic Surgery Specialists
200 Stony Brook Court Newburgh, NY 12550
Phone: (845) 863-1772
yourfacemd.com

Rubinstein Plastic Surgery Center
160 Summit Avenue ,Suite 202 Montvale, NJ 07645
Phone: (201) 391-1135
Rubinsteinplasticsurgerycenter.com

SOURCE: Rubinstein Plastic Surgery Center

View the original press release on ACCESS Newswire

Iframe sync
error: Content is protected !!